276 related articles for article (PubMed ID: 26682993)
21. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
[TBL] [Abstract][Full Text] [Related]
22. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
Vassos E; Panas M; Kladi A; Vassilopoulos D
J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
[TBL] [Abstract][Full Text] [Related]
23. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.
Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F
Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288
[TBL] [Abstract][Full Text] [Related]
24. Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.
Sipilä JOT; Kauko T; Päivärinta M; Majamaa K
J Neurol; 2017 Oct; 264(10):2095-2100. PubMed ID: 28849405
[TBL] [Abstract][Full Text] [Related]
25. Clinical and genetic data of Huntington disease in Moroccan patients.
Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
[TBL] [Abstract][Full Text] [Related]
26. A clinical study of patients with genetically confirmed Huntington's disease from India.
Murgod UA; Saleem Q; Anand A; Brahmachari SK; Jain S; Muthane UB
J Neurol Sci; 2001 Sep; 190(1-2):73-8. PubMed ID: 11574110
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan.
Nakashima K; Watanabe Y; Kusumi M; Nanba E; Maeoka Y; Nakagawa M; Igo M; Irie H; Ishino H; Fujimoto A; Goto J; Takahashi K
Neuroepidemiology; 1996; 15(3):126-31. PubMed ID: 8700304
[TBL] [Abstract][Full Text] [Related]
28. Survival of Huntington's disease patients in Serbia: longer survival in female patients.
Pekmezovic T; Svetel M; Maric J; Dujmovic-Basuroski I; Dragasevic N; Keckarevic M; Romac S; Kostic VS
Eur J Epidemiol; 2007; 22(8):523-6. PubMed ID: 17653603
[TBL] [Abstract][Full Text] [Related]
29. Age, CAG repeat length, and clinical progression in Huntington's disease.
Rosenblatt A; Kumar BV; Mo A; Welsh CS; Margolis RL; Ross CA
Mov Disord; 2012 Feb; 27(2):272-6. PubMed ID: 22173986
[TBL] [Abstract][Full Text] [Related]
30. Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.
Roth J; Zidovská J; Růzicková S; Havrdová E; Preiss M; Uhrová T; Línek V; Doubek P; Volfová M; Jech R; Bauer J; Růzicka E
Sb Lek; 1999; 100(1):39-44. PubMed ID: 10860124
[TBL] [Abstract][Full Text] [Related]
31. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.
Lee JH; Lee JM; Ramos EM; Gillis T; Mysore JS; Kishikawa S; Hadzi T; Hendricks AE; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Squitieri F; Gellera C; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Sequeiros J; Landwehrmeyer GB; ; Shoulson I; ; Myers RH; MacDonald ME; Gusella JF
Biochem Biophys Res Commun; 2012 Aug; 424(3):404-8. PubMed ID: 22771793
[TBL] [Abstract][Full Text] [Related]
32. DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients.
Wang CK; Wu YR; Hwu WL; Chen CM; Ro LS; Chen ST; Gwinn-Hardy K; Yang CC; Wu RM; Chen TF; Wang HC; Chao MC; Chiu MJ; Lu CJ; Lee-Chen GJ
Eur Neurol; 2004; 52(2):96-100. PubMed ID: 15273431
[TBL] [Abstract][Full Text] [Related]
33. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
34. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
Langbehn DR; Brinkman RR; Falush D; Paulsen JS; Hayden MR;
Clin Genet; 2004 Apr; 65(4):267-77. PubMed ID: 15025718
[TBL] [Abstract][Full Text] [Related]
35. Late-onset Huntington's disease: a clinical and molecular study.
James CM; Houlihan GD; Snell RG; Cheadle JP; Harper PS
Age Ageing; 1994 Nov; 23(6):445-8. PubMed ID: 9231935
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of Huntington's disease and linked polymorphisms in the Indian population.
Saleem Q; Roy S; Murgood U; Saxena R; Verma IC; Anand A; Muthane U; Jain S; Brahmachari SK
Acta Neurol Scand; 2003 Oct; 108(4):281-6. PubMed ID: 12956863
[TBL] [Abstract][Full Text] [Related]
37. Behavioral symptoms associated with Huntington's disease.
Anderson KE; Marshall FJ
Adv Neurol; 2005; 96():197-208. PubMed ID: 16383221
[TBL] [Abstract][Full Text] [Related]
38. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
[TBL] [Abstract][Full Text] [Related]
39. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
40. Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes.
Vinther-Jensen T; Nielsen TT; Budtz-Jørgensen E; Larsen IU; Hansen MM; Hasholt L; Hjermind LE; Nielsen JE; Nørremølle A
Clin Genet; 2016 Mar; 89(3):320-7. PubMed ID: 26081309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
